We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
In a survey by the consulting firm Deloitte, device manufacturers said that the semiconductors they need are in such short supply that many will have to cut back on production. Read More
Non-White patients experience less accurate oxygen readings with pulse oximeters and receive less supplemental oxygen in intensive care units, researchers reported in the journal JAMA Internal Medicine. Read More
Leading devicemakers have pushed back against the FDA’s proposed annual appraisals of companies that participate in the agency’s Voluntary Improvement Program (VIP). Read More
The FDA’s annual announcement of planned enhancements to its electronic medical device report (eMDR) portal advises devicemakers that use the agency’s Electronic Submissions Gateway (ESG) to update their submission systems accordingly. Read More
Virpax said it expects to complete stability testing, human factors testing for medical devices, safety studies and supplementary in-vitro studies. Read More
French in vitro diagnostics company bioMérieux is contributing its expertise to a joint venture to develop both diagnostics and antimicrobials to fight pathogens that have evolved into antimicrobial resistance (AMR). Read More
The European Commission has issued a regulation for manufacturers of high-risk, Class D in vitro diagnostics, giving them two years to comply with the EU’s In Vitro Diagnostic Regulation (IVDR). Read More
Sens. Elizabeth Warren (D-Mass.) and Chuck Grassley (R-Iowa) accused leading device manufacturers of trying to "undermine" the availability of over-the-counter hearing aids, in a newly published report. Read More
The FDA is proposing to reclassify two high-risk, class III devices — optical diagnostic devices for melanoma detection and electrical impedance spectrometers — into class II (special controls) subject to 510(k) clearance. Read More
The Office of Management and Budget has belatedly posted its Spring regulatory agenda for the federal government, including the following medical device-related proposed and final rules that the FDA is aiming to release. Read More
Sunnyvale, Calif.-based Aerin Medical’s VivAer Stylus treatment for nasal airway obstruction due to nasal valve collapse showed positive four-year results in a postmarket study. Read More